UnitedHealth Group’s Sir Andrew Witty will take a leave of absence running Optum to “co-lead a global effort of the World Health Organization” to develop a vaccine for the Coronavirus strain ...

Andrew Witty, who for years was the chief executive of one of the world’s largest pharmaceutical companies GlaxoSmithKline, will be stepping in as the new chief executive of Optum come July 1.

UnitedHealth Group’s fast-growing Optum healthcare services unit is rolling out what it hopes will be a “city-by-city” effort to make medical care more seamless to patients. Andrew Witty ...

Sir Andrew Witty, the high-ranking UnitedHealth Group Inc. executive who left earlier this year to spearhead Covid-19 vaccine development at the World Health Organization, is back at the company.

For one, the company is still growing the geographic reach of Optum Care, CEO Andrew Witty said during an event hosted by Bernstein on Thursday. In addition, its reach in the markets it serves may ...

Sir Andrew Witty is the CEO of Optum and the president of UnitedHealth Group. Richard Fleischman By Mark Reilly – Managing Editor, Minneapolis / St. Paul Business Journal ...

Andrew Witty — who became ... The retirement was short-lived. Witty joined UnitedHealth first as a director in August 2017 and then took over Optum, the company’s fast-growing health care ...

Optum CEO Andrew Witty will take a leave of absence from the company to co-lead efforts at the World Health Organization to develop a COVID-19 vaccine, UnitedHealth Group announced Wednesday.